PARNF fundamentals

Parnell Pharmaceuticals Holdings Ltd. operates as a veterinary pharmaceutical company. The firm engages in the development, manufacture and commercializing animal health solutions. It operates through the following segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. The Companion Animal segment sells osteoarthritis suite of products Zydax, Glyde and Tergive for canine and equine species. The Production Animal-U.S. segment includes reproductive hormone portfolio across production animals. The Production Animal-Rest of World segment provides reproductive hormone products outside of the U.S. The Manufacturing Operations segment involves in sterile manufacturing and release of pharmaceutical products. The company was founded on June 25, 2009 and is headquartered in Sydney, Australia.